Literature DB >> 25744156

Novel markers of endothelial dysfunction and inflammation in Behçet's disease patients with ocular involvement: epicardial fat thickness, carotid intima media thickness, serum ADMA level, and neutrophil-to-lymphocyte ratio.

Murat Yuksel1,2, Abdulkadir Yildiz3, Mustafa Oylumlu3, Fatih Mehmet Turkcu4, Mehmet Zihni Bilik3, Aysun Ekinci5, Bilal Elbey6, Ebru Tekbas3, Sait Alan3.   

Abstract

The etiology of Behçet's disease (BD) has not been fully elucidated. However, immunological and environmental factors, endothelial dysfunction (ED), and genetic susceptibility have been proposed to play a role. In this study, we aimed to evaluate epicardial fat thickness (EFT) together with serum asymmetric dimethylarginine (ADMA), carotid intima media thickness (CIMT), and neutrophil-to-lymphocyte ratio (NLR) in BD patients with ocular involvement. Thirty-six ocular BD patients (17 active and 19 inactive ocular involvement), and 35 age and sex-matched healthy controls were enrolled to this cross-sectional study. All patients underwent examinations with transthoracic echocardiography and carotid Doppler ultrasound. Serum ADMA levels, CIMT, EFT, and NLR were compared between groups, and their association with disease activity was evaluated. Behçet's disease patients had higher WBC counts, neutrophil counts, NLR, CIMT, EFT values, and serum ADMA levels than do healthy controls. The other biochemical, hematological, and echocardiographic parameters were comparable between the two groups. Behçet's disease duration was positively correlated with EFT and CIMT. Multivariate logistic regression analysis revealed that increased serum ADMA concentration and CIMT are independently associated with BD. Neutrophil counts, NLR, and serum ADMA level were higher, and lymphocyte count was lower in patients with active ocular BD compared to those of inactive ocular BD group. Carotid intima media thickness, serum ADMA level, EFT, and NLR were increased in ocular BD patients compared to healthy subjects. In addition, both serum ADMA level and NLR were associated with disease activity of ocular involvement. Increase in disease duration was associated with increase in CIMT and EFT which suggests that anatomical changes occur in time during the disease course. Increased CIMT, serum ADMA level, EFT, and NLR may provide new clues about the role of ED and inflammation in the etiopathogenesis of BD.

Entities:  

Keywords:  ADMA; Asymmetric dimethylarginine; Behçet’s disease; Carotid intima media thickness; Neutrophil to lymphocyte ratio; Rheumatic diseases

Mesh:

Substances:

Year:  2015        PMID: 25744156     DOI: 10.1007/s10067-015-2907-0

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  40 in total

1.  Echocardiographic epicardial fat thickness is associated with arterial stiffness.

Authors:  Byung Jin Kim; Bum Soo Kim; Jin Ho Kang
Journal:  Int J Cardiol       Date:  2012-06-21       Impact factor: 4.164

Review 2.  Elevated levels of asymmetric dimethylarginine (ADMA) as a marker of cardiovascular disease and mortality.

Authors:  Rainer H Böger; Renke Maas; Friedrich Schulze; Edzard Schwedhelm
Journal:  Clin Chem Lab Med       Date:  2005       Impact factor: 3.694

Review 3.  Criteria for diagnosis of Behçet's disease. International Study Group for Behçet's Disease.

Authors: 
Journal:  Lancet       Date:  1990-05-05       Impact factor: 79.321

4.  Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group.

Authors:  D H O'Leary; J F Polak; R A Kronmal; T A Manolio; G L Burke; S K Wolfson
Journal:  N Engl J Med       Date:  1999-01-07       Impact factor: 91.245

5.  Asymmetric dimethylarginine, L-arginine, and endothelial dysfunction in essential hypertension.

Authors:  Francesco Perticone; Angela Sciacqua; Raffaele Maio; Maria Perticone; Renke Maas; Rainer H Boger; Giuseppe Tripepi; Giorgio Sesti; Carmine Zoccali
Journal:  J Am Coll Cardiol       Date:  2005-08-02       Impact factor: 24.094

6.  Nitric oxide, lipid peroxidation and antioxidant defence system in patients with active or inactive Behçet's disease.

Authors:  S Buldanlioglu; S Turkmen; H B Ayabakan; N Yenice; M Vardar; S Dogan; E Mercan
Journal:  Br J Dermatol       Date:  2005-09       Impact factor: 9.302

7.  Acute systemic inflammation impairs endothelium-dependent dilatation in humans.

Authors:  A D Hingorani; J Cross; R K Kharbanda; M J Mullen; K Bhagat; M Taylor; A E Donald; M Palacios; G E Griffin; J E Deanfield; R J MacAllister; P Vallance
Journal:  Circulation       Date:  2000-08-29       Impact factor: 29.690

Review 8.  Etiopathogenesis of Behçet's disease with emphasis on the role of immunological aberrations.

Authors:  Violetta D Kapsimali; Meletios A Kanakis; George A Vaiopoulos; Phaedon G Kaklamanis
Journal:  Clin Rheumatol       Date:  2010-05-22       Impact factor: 2.980

9.  The relationship between neutrophil lymphocyte ratio and non-dipper hypertension.

Authors:  Mehmet Demir
Journal:  Clin Exp Hypertens       Date:  2013-02-06       Impact factor: 1.749

10.  Assessment of the neutrophil to lymphocyte ratio in young patients with acute coronary syndromes.

Authors:  Serkan Oztürk; Alim Erdem; Mehmet Fatih Ozlü; Selim Ayhan; Kemalettin Erdem; Mehmet Ozyaşar; Yusuf Aslantaş; Mehmet Yazıcı
Journal:  Turk Kardiyol Dern Ars       Date:  2013-06
View more
  11 in total

1.  Evaluation of development of subclinical atherosclerosis in children with uveitis.

Authors:  Seçil Conkar; Suzan Güven Yılmaz; İlker Özgür Koska; Afig Berdeli; Sevgi Mir
Journal:  Clin Rheumatol       Date:  2017-07-10       Impact factor: 2.980

2.  Neutrophil/lymphocyte ratio and platelet/lymphocyte ratio in Behçet's disease: which and when to use?

Authors:  Marwa Hammad; Omaima Zakaria Shehata; Shaimaa Mohamed Abdel-Latif; Amany Mohamed Mohiey El-Din
Journal:  Clin Rheumatol       Date:  2018-07-07       Impact factor: 2.980

Review 3.  Cardiovascular disease in patients with autoinflammatory syndromes.

Authors:  Rainer Hintenberger; Agnes Falkinger; Kathrin Danninger; Herwig Pieringer
Journal:  Rheumatol Int       Date:  2017-11-01       Impact factor: 2.631

Review 4.  Knitting the Threads of Silk through Time: Behçet's Disease-Past, Present, and Future.

Authors:  Fahd Adeeb; Austin G Stack; Alexander D Fraser
Journal:  Int J Rheumatol       Date:  2017-09-10

5.  Serum PLR and LMR in Behçet's disease: Can they show the disease activity?

Authors:  Ying Jiang; Mingcui Zang; Shanshan Li
Journal:  Medicine (Baltimore)       Date:  2017-05       Impact factor: 1.889

6.  High Neutrophil-to-Lymphocyte Ratio Predicts Cardiovascular Mortality in Chronic Hemodialysis Patients.

Authors:  Han Li; Xiangxue Lu; Ruifang Xiong; Shixiang Wang
Journal:  Mediators Inflamm       Date:  2017-02-21       Impact factor: 4.711

7.  Neutrophil to lymphocyte ratio at diagnosis can estimate vasculitis activity and poor prognosis in patients with ANCA-associated vasculitis: a retrospective study.

Authors:  Sung Soo Ahn; Seung Min Jung; Jason Jungsik Song; Yong-Beom Park; Sang-Won Lee
Journal:  BMC Nephrol       Date:  2018-07-31       Impact factor: 2.388

8.  Meta-Analysis of Asymmetric Dimethylarginine Concentrations in Rheumatic Diseases.

Authors:  Gian Luca Erre; Arduino Aleksander Mangoni; Floriana Castagna; Panagiotis Paliogiannis; Ciriaco Carru; Giuseppe Passiu; Angelo Zinellu
Journal:  Sci Rep       Date:  2019-04-01       Impact factor: 4.379

9.  Prognostic Value of Neutrophil-To-Lymphocyte Ratio and Platelet-To-Lymphocyte Ratio for Renal Outcomes in Patients with Rapidly Progressive Glomerulonephritis.

Authors:  Yukari Mae; Tomoaki Takata; Ayami Ida; Masaya Ogawa; Sosuke Taniguchi; Marie Yamamoto; Takuji Iyama; Satoko Fukuda; Hajime Isomoto
Journal:  J Clin Med       Date:  2020-04-15       Impact factor: 4.241

10.  Can we use the neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and mean platelet volume values for the diagnosis of anterior uveitis in patients with Behcet's disease?

Authors:  Atil Avci; Deniz Avci; Fatma Erden; Ertas Ragip; Ali Cetinkaya; Kemal Ozyurt; Mustafa Atasoy
Journal:  Ther Clin Risk Manag       Date:  2017-07-17       Impact factor: 2.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.